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Mechanobiology has shifted our understanding of fundamental cellular and physiological
functions. Changes to the stiffness of the extracellular matrix, cell rigidity, or shape of the
cell environment were considered in the past to be a consequence of aging or
pathological processes. We now understand that these factors can actually be causative
biological mediators of cell growth to control organ size. Mechanical cues are known to
trigger a relatively fast translocation of specific transcriptional co-factors such as MRTFs,
YAP and TAZ from the cytoplasm to the cell nucleus to initiate discrete transcriptional
programs. The focus of this review is the molecular mechanisms by which biophysical
stimuli that induce changes in cytoplasmic actin dynamics are communicated within
cells to elicit gene-specific transcription via nuclear localisation or activation of specialized
transcription factors, namely MRTFs and the Hippo pathway effectors YAP and TAZ. We
propose here that MRTFs, YAP and TAZ closely collaborate as mechano-effectors.
Keywords: Mechanotransduction, Actin, Myocardin, MRTF, YAP, TAZ, β-catenin, Epithelial-
mesenchymal transitionBackground
Mechanical signaling refers to the process by which a physical force such as pushing,
pulling or shear stress can trigger a signaling event, which stimulates the transfer of infor-
mation throughout the cell to elicit a response. The molecular mechanisms’ by which cells
sense and respond to mechanical stimuli are referred to as mechanotransduction. Stretch-
activated ion channels, integrin based cell-extracellular matrix (ECM) adhesions, cadherin
based cell-cell contacts, receptors, cytoskeletal filaments as well as many other sensors and
effectors have been shown to contribute to mechanotransduction. The cellular response to
mechanical signals involves reorganization of the cytoskeleton, effecting cellular shape,
orientation, polarity, migration, and gene expression.
Extracellular stimuli that alter actin dynamics are highly diverse and include soluble fac-
tors such as hormones and chemokines, or physical interactions between neighboring cells
and the ECM. These signals are perceived by various receptor proteins including G
protein-coupled receptors (GPCRs), Receptor Tyrosine Kinases (RTKs), and receptors for
integrin, transforming growth factor-β (TGFβ), and E-cadherin signaling. Receptors link to
Rho GTPases via selective Rho guanine nucleotide exchange factors (GEFs) that activate
Rho proteins by catalyzing the exchange of GDP for GTP. Once activated, Rho GTPases
regulate numerous downstream effector proteins to modulate actin polymerization chiefly
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least 20 different Rho GTPases from eight subfamilies, the best-characterised being RhoA,
Rac and Cdc42 (for a review of Rho GTPase signal transduction see [1, 2]).
Due to the complex nature of actin dynamics, adequate cellular response to extracel-
lular stimuli not only requires polymerization and/or disassembly of actin filaments,
but also coordinated synthesis of the myriad of structural proteins and regulatory fac-
tors that accompany this process. Cells must therefore be able to sense the status of
actin cytoskeleton organization and be able to communicate this to the cell nucleus to
regulate gene transcription. How this occurs in the cell remained a mystery until the
seminal discovery that actin polymerization is the trigger for nuclear localisation of
myocardin-related transcription factor (MRTF) to stimulate serum response factor
(SRF)-dependent transcription [3]. Since then, other factors that respond to and ac-
tively regulate actin dynamics have been identified.
Whilst the function of cytoplasmic actin in regulating gene expression has been known
for more than a decade, more recent investigations have shown that nuclear actin can also
regulate gene transcription via its requirement for the activity of all three RNA polymerases,
and its association with ribonucleoproteins and chromatin remodeling complexes (reviewed
in [4]). Nuclear actin and its functional implication for general transcriptional activity will
not be discussed here in detail. Rather this review will focus on how changes in cytoplasmic
actin dynamics affect gene-specific transcription via nuclear localisation or activation of spe-
cialized transcription factors, namely MRTFs and the Hippo pathway effectors Yes-
associated protein (YAP) and its paralog transcriptional coactivator with PDZ-binding motif
(TAZ), in addition to some less characterised factors such as β-catenin, the NF-κB, Nrf2
and Foxj1a transcription factors, and epigenetic regulator HDAC3. Important to note is that
in addition to their role in mechanotransduction, the transcription factors discussed in this
review are involved in regulating various other cellular processes in response to alternate
stimuli e.g., chemical ligand binding, and do not function solely as mechanotransducers.
Myocardin-related transcription factor (MRTF) family
SRF is a member of the MADS-box family of transcription factors that was first described
by Treisman in 1986. It is the factor that binds to the serum response element (SRE, or
CArG sequence: CC[A/T]6GG) in the promoter region of c-fos to mediate cellular response
following serum stimulation [5]. SRF is abundantly expressed in many cell types and directs
the transcription of target genes in response to various signaling cascades. SRF target genes
include ‘immediate-early’ genes, encoding for proteins required for re-entry into the cell
cycle e.g., c-fos and egr-1, muscle specific genes e.g., alpha-actin and tropomyosin, regulators
of actin dynamics and cell motility e.g., gelsolin and vinculin, and microRNAs (miR-1, miR-
133a) (see review by [2]). Thus SRF is an important regulator of cellular function including
growth, proliferation, migration, cytoskeletal organization and differentiation.
Myocardin (MYOCD), MRTF-A (MAL1/MKL1) and MRTF-B (MKL2/MAL16) are
members of the MRTF family (Fig. 1) that interact with SRF to activate a panel of genes
[6–8]. Notably, MRTFs exhibit different patterns of expression. Whilst myocardin is
specifically expressed in cardiac and a subset of smooth muscle cells, MRTF-A and -B
are expressed in a range of embryonic and adult tissues [8]. MRTFs also perform separ-
ate functions in vivo, revealed by knockout studies in mice. MYOCD-null mice survive
only to embryonic day 10.5 (E10.5) exhibiting gross vascular defects likely due to
Fig. 1 Schematic representation of the protein structure of the human myocardin-related transcription factor
family. Various domains and motifs within the family members myocardin (MYOCD), myocardin-related
transcriptional factor A (MRTF-A) and myocardin-related transcriptional factor B (MRTF-B) mediate specific
functions: RPEL domain (purple) mediates cytoplasmic localisation and actin binding, basic (+; blue) and
glutamine-rich (Q; burgundy) regions facilitate interaction with Serum Response Factor, whereas SAP domain
(green) dictates promoter specificity. Leucine zipper (LZ; lime) mediates dimerization, and TAD (red) is
a transcriptional activation domain. The PPxY motif (orange) mediates interaction with WW domains of
partner proteins such as YAP. In MYOCD, PPSY is located at amino acid positions 768–771; in MRTF-A, PPGY is
at amino acid positions 725–728; and in MRTF-B, PPRY is at amino acid positions 882–885. The number of
amino acids for each protein is indicated
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mid-gestation E14.5, with defects in cardiac outflow tract morphogenesis mimicking
congenital heart disease [10, 11]. In contrast, MRTF-A is dispensable for normal devel-
opment since MRTF-A-knockout mice are viable and fertile. This is surprising, since it
is the most ubiquitously expressed of the MRTF family members. MRTF-A is however
required for prolonged lactation, attributed to its role in differentiation and survival of
myoepithelial cells, which are required for maintenance of lactation [12, 13].
Interestingly, despite sharing similar protein structure MRTF family members are subject
to differential intracellular regulation. Whereas myocardin is usually localised to the cell nu-
cleus, MRTF-A and -B are predominantly localised to the cytoplasm and only translocate to
the nucleus following stimulation (reviewed in [14]). Nuclear translocation of MRTF after
serum stimulation is controlled by Rho GTPases via actin dynamics (Fig. 3a). In a series of
elegant experiments, Miralles et al. [3] showed that MRTF-A binds monomeric actin via
three N-terminal RPEL motifs, effectively sequestering it in the cytoplasm. Rho-mediated
actin polymerization releases MRTF, resulting in increased nuclear accumulation where it
associates with SRF to drive transcription.
Treatment with drugs to alter the actin polymerization status provided evidence to sup-
port actin dynamics as the trigger for MRTF-A translocation and SRF activation. Latruncu-
lin B, which impairs F-actin formation by sequestration of actin monomers, prevents
nuclear accumulation of MRTF-A. The opposite effect was observed following treatment
with cytochalasin D to promote actin dimerization [3]. These findings were recapitulated
using overexpression of actin mutants that either favor (Val159Asn and Ser14Cys) or inhibit
(Glu13Arg and Arg62Asp) actin polymerization [15]. Nuclear translocation of MRTF is also
regulated in a serum-independent manner by the muscle-specific actin binding protein
STARS (striated muscle activator of Rho signaling). STARS enhances actin polymerization,
through a mechanism that requires its C-terminal actin-binding domain and RhoA, result-
ing in increased nuclear accumulation of MRTF [16]. Myocardin contains divergent RPEL1
and 2 motifs that have a lower affinity for actin compared to MRTF [17]. In contrast, bind-
ing of myocardin to the nuclear import machinery (the importin α/β1 heterodimer) (Fig. 3a)
is stronger than that of MRTF-A/B [18]. Furthermore, access to two N-terminal leucine rich
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and the MRTFs [19]. Taken together, these factors explain the differences observed between
myocardin and MRTF-A/B subcellular localisation.MRTFs are mechanical sensors linking actin dynamics to SRF-mediated gene transcription
Before MRTFs were known to bind SRF to activate gene transcription, Sotiropoulos et al.
[20] showed that SRF activation by the actin regulator LIM kinase-1 (LIMK1) is dependent
on its ability to promote F-actin stabilization via phosphorylation of cofilin. Activation of
SRF by actin dynamics is sufficient to induce transcription of vinculin, cytoskeletal actin
and srf itself. Using Srf-null embryonic stem cells, Schratt et al. [21] demonstrated that cell
spreading, adhesion and migration is impaired by loss of SRF, due to an inability to form
focal adhesion plaques and stress fibers. Consistent with previous reports identifying
MRTF-A as the mediator of SRF activation in response to actin dynamics in mammals [3],
analysis of border cell migration during Drosophila oogenesis revealed nuclear localisation
of MAL-D (Drosophila ortholog of MRTF) correlates with the stretched shape of migrating
cells [22]. Moreover, nuclear localisation of the MAL-D/SRF complex is required to estab-
lish a robust F-actin cytoskeleton, necessary for invasive migration [22]. The authors’
propose that tension-induced MAL-D nuclear accumulation may provide positive feedback
regulation for cytoskeletal actin dynamics and migration.
Using collagen coated magnetic beads the McCulloch group applied static tensile forces
to cultured cardiac fibroblasts to further study MRTF regulation by mechanical stress. The
applied force induced Rho-dependent actin assembly, promoting nuclear translocation of
MRTF and activation of SRF-dependent gene transcription as determined by α-smooth
muscle actin (α-SMA) expression [23]. In a comprehensive report, nuclear accumulation of
MRTF-A stimulated by serum, actin drugs or mechanical stress was blocked in cells main-
tained at tensional homeostasis [24]. Tensional homeostasis refers to the situation in which
there is a balance between the external (ECM) and internal (cytoskeletal) forces. This was
achieved by plating cells on mechanically loaded, anchored matrices, and was accompanied
by a higher G/F-actin ratio, mediated by increased cofilin expression. From these studies it
is clear that because MRTFs can respond directly to changes in actin dynamics, any situ-
ation that exposes cells to mechanical forces will elicit a robust transcriptional response me-
diated by MRTF/SRF signaling.MRTFs are “master regulators” of epithelial-mesenchymal transition (EMT)
Epithelial–mesenchymal transition (EMT) is a cellular phenotypic shift accompanied by
changes in gene expression of numerous transcription factors and cytoskeletal proteins that
enable cells to dissociate their cell–cell contacts and migrate. EMT governs a variety of de-
velopmental processes including gastrulation, neural crest development, and heart valve for-
mation (reviewed in [25]). EMT also plays a significant role in the development of
pathological conditions, namely organ fibrosis and cancer progression. Increased ECM ri-
gidity is a hallmark of fibrosis and metastasis, and mechanical tension has been identified as
a regulator of EMT. Due to their role in regulating and responding to changes in the actin
cytoskeleton, it is not surprising that the MRTFs are implicated in EMT.
TGFβ is a major inducer of EMT, acting via several different mechanisms including
SMAD-dependent and -independent signaling pathways [26]. TGFβ triggers the Rho-
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transcription of slug, a repressor of E-cadherin and positive regulator of EMT [27]. More-
over, MRTFs increase expression of actin cytoskeletal proteins (caldesmon, tropomyosin
and β-actin) to induce reorganization of the cytoskeleton, effectively operating as a feed-
forward mechanism for MRTF-activation. Disruption of cell-cell junctions by removal of
calcium is also sufficient to enhance nuclear accumulation of MRTF-A and SRF, leading to
activation of α-SMA, a marker of cells that have transdifferentiated to the myofibroblast
phenotype [28]. A 2010 study by Gomez et al. found that a sheet of mammary epithelial
cells treated with TGFβ displayed variability in expression of EMT markers [29]. Investiga-
tion of the relative cellular forces across the cell sheet revealed that cells within regions ex-
periencing the highest mechanical stress preferentially underwent EMT. Because nuclear
localisation of MRTF-A correlates directly with mechanical stress, tissue geometry and the
resultant variability in cytoskeleton dynamics dictates EMT responsiveness following TGFβ
stimulation via regulation of MRTF activation. Along the same lines, restriction of cell
spreading [30] and decreased matrix rigidity [31] both prevent MRTF-A nuclear transloca-
tion and block transdifferentiation. These studies provide a clear link between mechanical
stress, MRTF-A translocation and EMT, and contribute to our understanding of the
complex nature of how biophysical cues influence biological outcome.Role of MRTFs in fibrosis and cancer
Aberrant EMT activation underlies development of tissue fibrosis and cancer progression
[25]. Due to its role in regulating EMT, MRTF-A has been linked to multiple pathologies
including lung and liver fibrosis, and metastasis in a variety of human cancers. Increased
nuclear MRTF-A was observed in a mouse model of lung fibrosis (intratracheal bleomycin)
and samples from patients with idiopathic pulmonary fibrosis [32]. Functionally, inhibition
of MRTF-A mechanosignaling via treatment with the ROCK inhibitor fasudil during the
fibrotic stage of lung injury, or genetic ablation of MRTF-A, protected mice from experi-
mental lung fibrosis [32]. Similarly, knockout of MRTF-A significantly reduced carbon
tetrachloride (CCl4)-induced liver fibrosis in mice [33]. MRTF-A null mice exhibited a
suppressed hepatic stellate cell response as determined by reduced hepatic stellate cell
activation markers e.g., type I collagen (Col1a) and α-SMA [33]. This finding is significant
since in the majority of cases, chronic liver injury characterised by liver fibrosis precedes the
development of primary liver cancer.
Increased MRTF-A RNA expression correlates with breast cancer metastasis in human
patient samples [34]. MRTF-A, together with STAT3, promotes migration of MDA-MB-
231 breast cancer cells via up-regulation of Myl9 and Cyr61 [34]. Myl9, a component of the
actomyosin contractile apparatus, and the ECM-associated signaling protein Cyr61 have
both been implicated in the invasive characteristics of tumour cells [35, 36]. As in breast
cancer, MRTF-A expression correlates with a more invasive lung cancer phenotype [37].
Depletion of MRTF decreased in vitro and in vivo migration and invasion, likely due to re-
pression of matrix metalloproteinase 9 (MMP9) expression [37], an MRTF-A target that
has been implicated in lung tumorigenesis [38].
In the pancreas, increased MRTF-A and –B expression promotes generation of stem cell-
like cells from normal cells via up-regulation of microRNAs associated with EMT and can-
cer initiating cells [39]. Overexpression of MRTF-A and –B promoted pancreatic cancer
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is associated with resistance to the chemotherapeutic agent gemcitabine [39]. Alteration to-
wards a more stem cell-like phenotype and increased drug resistance is meaningful since
less differentiated tumours tend to be more aggressive and typically respond poorly to trad-
itional chemotherapeutics [40].Therapeutic targeting of MRTF-A
Accumulating evidence highlighting MRTF-A as a mediator of fibrotic disease and metasta-
sis suggests that targeting MRTF-SRF signaling for therapy could be beneficial. CCG-1423,
a small molecule inhibitor of RhoA signaling [41], inhibits nuclear accumulation of MRTF-
A by blocking its interaction with importin α/β1 through binding to the N-terminal basic
domain of MRTF-A [42]. This discovery paved the way for development of second-
generation compounds that have improved cytotoxicity e.g., CCG-100602 and CCG-203971
[43]. Using two in vitro models of intestinal fibrogenesis treatment with second-generation
MRTF-A inhibitors was able to block both physical (matrix stiffness-induced) and biochem-
ical (TGFβ-induced) fibrogenesis [43]. MRTF-A inhibition reduced expression of actin con-
tractile (Mylk) and fibrogenic (Col1a) genes and α-SMA protein expression.
Important to note however, is that myofibroblast differentiation is a normal physio-
logical response to injury. During wound healing keratinocytes gain mesenchymal features
to enable migration and re-epithelialisation [44]. Similarly, cardiac remodelling following
myocardial infarction requires differentiation of fibroblasts to myofibroblasts, and this
process is regulated by MRTF-A [45]. Increased MRTF-A activation could therefore be
harnessed therapeutically to accelerate the wound healing process. The small molecule
isoxazole (ISX) was previously shown to promote myofibroblast differentiation of cardiac
progenitor cells [46]. Subsequently, ISX was found to stimulate MRTF-A dependent gene
expression via regulation of MRTF-A stability, though the mechanism for this is unclear
[47]. Importantly, treatment of dermal biopsies in mice with ISX significantly accelerated
wound closure and suppressed the inflammatory response [47], indicating that modula-
tion of MRTF-A activity is a feasible option to promote wound healing in humans.SRF-independent roles of MRTF-mechanosignaling
The function of MRTF as a mechanosensor is not completely reliant on its interaction with
SRF. Tenascin-C (TNC) is an ECM protein that is highly expressed in tissues experiencing
increased mechanical stress such as tissue remodeling, wound healing and tumorigenesis
(reviewed in [48]). Investigation of the mechanism of TNC up-regulation in response to
mechanical stress identified a SAP domain-dependent, SRF-independent interaction of
MRTF-A with the TNC promoter [49]. In a follow-up publication the same group identified
a set of breast cancer specific genes, including TNC, that are regulated by MRTF-A in an
SRF-independent manner [50]. Expression of this gene set is implicated in regulation of cel-
lular proliferation, motility and cancer, and correlates with poor patient prognosis [50].
More recently, MRTF-A has been implicated in the regulation of promoter methylation
status to control gene transcription. MRTF-A coordinates Histone H3 Lysine 4 (H3K4)
methylation on the MMP9 promoter to drive lung cancer cell migration and invasion [37].
H3K4 methylation is catalyzed by the COMPASS/COMPASS-like methyltransferase com-
plex, and MRTF-A recruits ASH2, a member of this complex, to activate MMP9
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fibrogenic gene promoters (e.g., Col1a1, Col1a2 and Acta2) to activate their transcription
and switch on a pro-fibrogenic transcriptional program [33]. Silencing of COMPASS
components significantly down-regulated the expression of MRTF-A target genes and
blocked experimental liver fibrosis in mice [33]. The discovery that MRTF can regulate gene
expression epigenetically will no doubt lead to the identification of novel MRTF-regulated
target genes, and adds to our understanding of the complex mechanisms governing
mechanotransduction.
The Hippo signaling pathway
The Hippo signaling pathway is a complex network of proteins that control organ size via
regulation of cellular proliferation, survival and differentiation. Initially discovered by genetic
mosaic screens in Drosophila, the core of the Hippo pathway comprises a pair of highly con-
served kinases and their adaptor proteins that, in mammals, centers on two effectors: YAP
[51] and TAZ (also known as WWTR1) [52] (Fig. 2). YAP and TAZ are potent transcrip-
tional coactivators that associate with various DNA-binding proteins e.g., TEAD factors, to
drive gene transcription. For a comprehensive review of the Hippo pathway, its regulators
and physiological functions, the reader is directed to two excellent reviews [53, 54].
Triggered by various upstream stimuli, for example cell-cell contact [55], the MST1/2
kinases together with the adaptor protein SAV1 (WW45) phosphorylate and activate
LATS1/2 and MOB [56, 57]. Activated LATS then phosphorylates YAP and TAZ on
specific serine residues [58–60]. Phosphorylation of Ser127 and Ser89 of YAP and TAZ,
respectively, generates a 14-3-3-protein binding site resulting in their cytoplasmic se-
questration [52, 61]. In addition, LATS phosphorylation on alternate residues marksFig. 2 Schematic representation of the protein structure of the single (YAP1-1) and double (YAP1-2) WW domain
isoforms of human YAP, and TAZ. YAP harbors a proline-rich region (Pro-rich; maroon) at its N-terminus which is
lacking in TAZ. DNA-binding is primarily mediated by interaction with TEAD proteins via the TEAD-binding domain
(orange), with phosphorylation on serine residue 94/51 in YAP and TAZ respectively important for this interaction.
WW domains (WW1; light blue and WW2; green) mediate protein-protein interactions with PPxY containing partners
including LATS and MRTFs [149] whereas the SRC homology 3 binding motif (SH3-BM; dark blue) enables YAP’s
association with the SH3 domain of Yes and Src protein-tyrosine kinases. The transcriptional co-activator activity of
YAP/TAZ is mediated by a strong transcriptional activation domain (TAD; red) that contains a coiled-coil (CC; yellow)
motif. Nuclear localisation of YAP/TAZ is mediated by a Post-synaptic density, Discs large, Zonula occludens-1-
binding motif (PDZ-BM; dark grey) [150]. Phosphorylation of serine 127/89 on YAP and TAZ respectively promotes
their cytoplasmic sequestration facilitated by interaction with 14-3-3-proteins. YAP and TAZ also contain
phosphodegron sequences (*) whereby phosphorylation of specific residues marks YAP and TAZ for degradation
by the proteasome. The number of amino acids for each protein is indicated
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Hippo signaling pathway thus inhibits YAP and TAZ activity. Mechanisms coupling
extracellular signals with the core Hippo kinase cassette are complex and not yet com-
pletely understood. Recently, mechanical cues from the cytoskeleton including cell
density, substrate stiffness, cellular tension, and GPCR signaling have been identified as
regulators of YAP/TAZ activity (Fig. 3b) (reviewed by [64, 65]).Fig. 3 Mechanosensitive regulators of gene transcription. Signaling diagrams showing mechanisms
linking mechanical cues to a myocardin-related transcription factor (MRTF) family mediated gene
expression, b Hippo-YAP/TAZ activity, and c crosstalk between the mechanosensing mediators
discussed in this review
Finch-Edmondson and Sudol Cellular & Molecular Biology Letters  (2016) 21:28 Page 9 of 23The Hippo pathway effectors YAP and TAZ respond robustly to mechanical cues
Early indications that YAP/TAZ activity is regulated by mechanical cues came from the im-
portant observation that YAP localisation and phosphorylation status is regulated by cell
density [55]. In sparsely populated cells YAP is predominantly localised to the nucleus and
in its active un-phosphorylated form. Contrastingly, in high density culture YAP is phos-
phorylated and localised to the cytoplasm, and this process is regulated by Hippo pathway
signaling [55]. A change in cell density alters both cell-cell contact (adhesion) and cell
morphology. To investigate regulation of the Hippo pathway by cell morphology, independ-
ent from cell adhesion, Wada et al. [66] grew single cells on variously sized fabricated
micropatterned cell adhesive areas (called microdomains). In cells grown on small domains
YAP is mostly cytoplasmic, whereas YAP localised to the nucleus on large domains [66].
Cell morphology-induced YAP localisation is dependent on LATS activity, indicating that
cell morphology is a Hippo pathway regulator.
YAP/TAZ localisation and activity is also controlled by the rigidity of the ECM. On
hard substrates YAP and TAZ are predominantly nuclear and become increasingly
cytoplasmic on softer substrates [67]. Importantly, ECM rigidity not only influences
YAP/TAZ activity in isolated cells, but also in confluent monolayers. Similarly, analysis
of YAP/TAZ localisation within a three-dimensional cell sheet demonstrated that varia-
tions in mechanical stress pattern YAP/TAZ nuclear localisation, where high stress cor-
relates with increased nuclear localisation, and vice versa [68]. The latter study also
revealed that mechanical stretching of contact inhibited cells i.e. exhibiting cytoplasmic
YAP, is sufficient to induce YAP/TAZ re-entry into the nucleus to stimulate cellular
proliferation [68]. This is important since it shows that mechanical stress is capable of
overcoming inactivation of YAP/TAZ by Hippo pathway signaling. Interestingly, all of
these studies identified actin cytoskeletal reorganization as a dominant regulator of
YAP and TAZ.
In support of this, a functional connection between GPCR/Rho signaling, cytoskeletal
reorganization, and YAP/TAZ activity has been elucidated. In response to chemical stim-
uli (e.g., LPA; lysophosphatidic acid and S1P; sphingosine 1-phosphophate) YAP and TAZ
are dephosphorylated and enter the nucleus [69, 70]. Notably, the status of F-actin
polymerization correlates with YAP activation. Similarly, YAP activity is regulated by cell
attachment/detachment and this is mediated by Rho deactivation and cytoskeletal
reorganization [71]. Indeed, YAP/TAZ inactivation is responsible for cell detachment-
induced anoikis, which is a specific type of apoptosis [71]. In these studies the LATS ki-
nases were found to be the major regulator of YAP/TAZ activity in response to GPCR
stimulation [69, 71], though intriguingly, GPCR signaling can either activate or inhibit
YAP activity depending on the particular G protein coupled to the receptor [69]. In gen-
eral we can consider that increased Rho GTPase activity and actin polymerization acti-
vates, whereas destabilisation of actin inhibits, YAP and TAZ (Fig. 3b).Mechanisms linking mechanical signals to YAP/TAZ activity
Unlike MRTF, YAP and TAZ are not known to directly bind actin; rather YAP and
TAZ response to mechanical cues is controlled by actin binding proteins that are re-
cruited to, and regulated by, the cytoskeleton. As alluded to above, actin polymerization
and particularly the formation of stress fibers is a chief regulator of YAP/TAZ activity.
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proteins A or B, or capulet (which sequesters actin monomers) induced a strong over-
growth phenotype via increased nuclear localisation of Yorkie (Yki, Drosophila YAP
ortholog) [72, 73]. Inhibition of stress fiber formation by treatment with latrunculin A
and cytochalasin D prevents nuclear accumulation of YAP/TAZ and abolishes their
transcriptional activity following a range of stimuli such as cell attachment and ma-
nipulation of cell morphology [66, 67, 69, 71]. Moreover, depletion of F-actin-capping
and -severing proteins (CapZ, Cofilin, and Gelsolin) is sufficient to induce YAP/TAZ
nuclear localisation and gene expression in high density cell cultures in which YAP/
TAZ have been inactivated [68]. Remarkably, while some studies found mechanical
regulation of YAP/TAZ to be independent of the Hippo pathway [67, 68, 70], others
show that the LATS kinases are essential [66, 69, 71].
Whether there truly are both Hippo-dependent and -independent mechanisms linking
stress fibers to YAP activity is unclear. Indeed it remains to be elucidated even how LATS
activity is regulated by actin polymerization. Recently, the Ste-20 kinase Happyhour and its
mammalian counterparts MAP4K1/2/3/5 were found to regulate LATS activity in response
to F-actin polymerization via direct phosphorylation of its hydrophobic motif [74] (Fig. 3b).
This corroborates previous data demonstrating LATS Ser909 and Thr1079 phosphorylation
is altered by GPCR signaling [69], and justifies the dispensable nature of MST1/2 for YAP/
TAZ mechano-regulation, though the link between actin polymerization and MAP4K1/2/3/
5 activation remains to be determined.
A mechanism linking mechanical forces to LATS was identified in Drosophila wing im-
aginal discs. In response to increasing cytoskeletal tension Jub, the ortholog of mamma-
lian Ajuba and a negative regulator of Warts (Drosophila LATS ortholog), preferentially
localises to apical junctions via its association with α-catenin, an actin associated protein
[75]. Jub is a negative regulator of Warts and recruits Warts to junctions in a tension-
dependent manner (Fig. 3b). The outcome of this is that increased tension within the
cytoskeleton increases Drosophila wing growth due to increased Yki activity and vice
versa [75]. A second study from the same group identified inhibition of LATS by LIMD1,
another member of the mammalian Ajuba protein family, as the mechanism linking cyclic
stretching and YAP activity in mammalian cells [76]. Mechanical strain activates c-Jun N-
terminal kinase (JNK) [77]. Using specific JNK inhibitors and shRNA-mediated depletion
the authors observed that JNK activates YAP activity in response to cyclic stretching [76].
Phosphorylation of LIMD1 by JNK increases it’s binding to LATS, effectively blocking
YAP/TAZ phosphorylation.
The role of LATS in transducing mechanical signals to YAP/TAZ is complicated by the
fact that Hippo signaling exhibits feedback to influence actin assembly. F-actin accumu-
lates abnormally in Drosophila when Hippo pathway activity is reduced or abolished, in-
dependently of Yki activity [73]. Zyxin, a promoter of actin polymerization that is
regulated by mechanical forces [78], has been shown to interact directly with Warts/LATS
in at least two studies. FAT, a cadherin transmembrane receptor, regulates localisation of
the myosin Dachs, which subsequently binds zyxin and stimulates its binding and inhib-
ition of Warts [79]. Separate to its role in the Hippo pathway, LATS targets phosphory-
lated zyxin to the mitotic apparatus to regulate actin dynamics during mitosis [80].
Interestingly, zyxin can also promote the interaction of Yki and Scalloped (Drosophila
TEAD ortholog) to drive Yki target gene expression and tissue growth [81]. Moreover, yet
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actin polymerization [82]. Hence involvement of the Hippo pathway in actin-mediated
YAP/TAZ regulation is multifaceted, and it is likely that LATS participates via more than
one mechanism simultaneously.
Important to highlight is the recent report by Das et al. [83] that purports the uncoupling
of phosphorylation and F-actin mediated nuclear localisation of YAP in non-contact inhib-
ited cells. Specifically, in sparsely populated cells, the authors observed that despite in-
creased phosphorylation of YAP upon inhibition of actomyosin contractility (by treatment
with blebbistatin), YAP protein remained localised to the nucleus, including phosphorylated
YAP [83]. This was in stark contrast to cells treated with latrunculin A (to de-polymerize
actin), in which YAP was effectively excluded from the nucleus, even when a LATS
phosphorylation-insensitive mutant (Ser127Ala equivalent) was utilised. These novel results
suggest that the control of YAP localisation by actin polymerization/de-polymerization can
override the canonical Hippo pathway-mediated regulation of YAP.
Angiomotins (AMOTs) are known regulators of YAP/TAZ localisation and activity via
Hippo-dependent [84] and –independent [85] mechanisms. AMOTs bind to F-actin, and
in response to perturbations of the actin cytoskeleton, dissociate from actin to bind and
sequester YAP in the cytoplasm [86] (Fig. 3b). Activated Hippo pathway signaling further
enhances this process, since phosphorylation of AMOT by LATS inhibits its F-actin bind-
ing to promote YAP cytoplasmic localisation [87]. Interestingly, AMOTs are required for
regulation of YAP localisation induced by a number of stimuli including increased cell
density, treatment with actin depolymerizing drugs, or GPCR activation by serum with-
drawal [86]. Hence AMOTs are yet another group of proteins that connect F-actin archi-
tecture to YAP/TAZ regulation.
The spectrin network is one of the most recently identified regulators of YAP/TAZ ac-
tivity in response to mechanical stimuli. Spectrin functions as scaffold protein at the
membrane–cytoskeleton interface via cross-linking of short F-actin filaments, and can
bind integral membrane proteins (reviewed in [88]) (Fig. 3b). Reports from three different
groups identified spectrin as a regulator of Yki/YAP in Drosophila and mammalian cells
[89–91]. Mutation or depletion of spectrin subunits in Drosophila induces Yki-dependent
cell polarity defects or tissue overgrowth. Although one study found that dysregulation of
apical spectrin alters the activity of the upstream Hippo pathway regulator Expanded [90],
the consensus appears to be that the basolateral spectrin network regulates cortical acto-
myosin tension, potentially via phosphorylation of non-muscle myosin II [89], which in
turn regulates Yki/YAP/TAZ activity by an as yet unidentified mechanism. Notably, spec-
trin does not alter Ajuba/Warts localisation to apical junctions [89–91], nor is there evi-
dence for the involvement of JNK activation [90].
Integration of the wide array of biochemical and mechanical cues encountered by a cell
is complex, and under ever-changing conditions can be extremely difficult to consolidate.
In the report from Sun et al. [92], the authors present a computational model that inte-
grates multiple components involved in mechanotransduction including adhesion com-
plexes, intracellular signal transmission, and cytoskeleton dynamics, with known
regulatory pathways directing transcriptional programs such as Hippo-YAP/TAZ and
SRF/MRTF signaling [92]. Using this model, the effect of changes in various signaling
molecules on YAP/TAZ activity can be predicted, revealing for example that overexpres-
sion of the adhesion molecule FAK is expected to increase YAP/TAZ activity in cells
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TAZ is more sensitive to changes in ECM properties than SRF/MRTF [92]. This is an in-
triguing prediction that is in contrast to the observation that MRTF-A translocated to the
nucleus three times faster than YAP in response to cyclic stretching of primary mouse
embryonic fibroblasts [93]. Given the relatively recent arrival of YAP/TAZ in the field of
mechanotransduction, there is no doubt researchers will endeavor to fully delineate the
differences and similarities between MRTF and YAP/TAZ experimentally.Biological outcomes of YAP/TAZ mechanotransduction: development and differentiation
As introduced above, the Hippo pathway is a critical regulator of organ size during develop-
ment and tissue homeostasis in the adult. Furthermore, dysregulation of Hippo signaling
underlies the development and progression of numerous types of human cancer. It is not
surprising therefore that mechanical signaling has been linked to the regulation of YAP/
TAZ activity in a variety of biological contexts in particular cellular differentiation, fibrosis
and cancer cell invasion. Specification of the trophectoderm and inner cell mass lineages in
the mouse blastocyst correlates with cell polarization and YAP localisation [94, 95]. Troph-
ectoderm derives from outer cells where YAP is nuclear and actively promoting transcrip-
tion of trophectoderm-specifying genes. Inhibition of Rho-ROCK signaling during the early
stages of embryogenesis results in activation of the LATS kinases [96]. The subsequent re-
duction in nuclear localised YAP correlates with mislocalisation of key components of the
apical-basal cell polarity, and impairs trophectoderm formation [96].
Truncation of YAP in the medaka fish hirame (hir) mutant results in a markedly flat-
tened body characterised by tissue flattening and misalignment [97]. YAP knockdown in
wild-type embryos recapitulated the hir phenotype, and the phenomenon could be imi-
tated with human cells using an in vitro three-dimensional spheroid culture system. The
Rho GTPase activating protein ARHGAP18 was identified as an effector of YAP that con-
trols actomyosin-mediated tissue tension [97]. This study identifies YAP as essential for
the attainment of proper three-dimensional body shape. Remarkably, the orientation of
body flattening correlated with the direction of gravity. Thus perhaps YAP is the long
sought after sensor of gravity proposed nearly a century ago by D’Arcy Thompson [98]. Ei-
ther way, these studies show that from the very early stages of development, YAP, and
most likely TAZ, is essential for proper development/differentiation.
Mechanical signal regulation of YAP/TAZ is also strongly linked to cell fate determin-
ation of multiple lineages, in particular neuronal and osteogenic differentiation. Studies
from two groups found that culture of human pluripotent stem cells (hPSCs) on compli-
ant versus rigid substrates markedly improved differentiation of hPSCs to post-mitotic
motor neurons [99, 100]. Inhibition of nuclear localised YAP by LATS activation was
identified as the driving factor for increased neuronal differentiation on soft surfaces. Dis-
ruption of actin dynamics or depletion of YAP is sufficient to stimulate neuronal differen-
tiation on rigid surfaces [99] whereas LATS1 knockdown inhibited differentiation on soft
surfaces [100]. YAP/TAZ associate with phosphorylated SMADs to inhibit their nuclear
localisation and maintain cellular pluripotency [101]. Interestingly, Sun et al. [100] ob-
served decreased phosphorylation and co-localisation of SMADs with YAP/TAZ on soft
substrates. Thus the mechano-regulated interplay between YAP/TAZ and SMADs is likely
to be important for rigidity-dependent neuronal differentiation.
Finch-Edmondson and Sudol Cellular & Molecular Biology Letters  (2016) 21:28 Page 13 of 23Similarly, the fate of mesenchymal stem cells is regulated by substrate density [102],
though remarkably modulation of YAP/TAZ abundance can switch the outcome of differ-
entiation. For example, YAP/TAZ knockdown enabled adipogenic differentiation on stiff
substrates that would usually produce osteoblasts [67]. The consequence of this can be
observed in a practical example where microgravity (weightlessness) induces observed
bone loss of approximately 1–2% per month in space. Osteogenic differentiation of bone
marrow derived mesenchymal stem cells was inhibited in cells grown in a clinostat to
simulate microgravity [103], and this correlates with dramatically decreased TAZ RNA
and protein expression. Inhibition of osteogenesis could be overcome by stimulation of
GPCRs with LPA to activate Rho-TAZ signaling, indicating this pathway may be thera-
peutically targeted to prevent bone loss during space flight.Biological outcomes of YAP/TAZ mechanotransduction: fibrosis and cancer
Like the MRTFs, YAP and TAZ have been implicated as key pro-fibrogenic regulators.
Fibrotic lung [104] and liver [105] exhibit increased YAP/TAZ staining due to a marked in-
crease in high YAP/TAZ expressing spindle-shaped fibroblasts. These cells exhibit pro-
nounced nuclear localisation of TAZ [104] or YAP [105], which correlates with
characteristic fibroblastic functions in vitro including proliferation, matrix synthesis, con-
traction and proliferation. Indeed YAP is essential for fibroblast activation: siRNA-
mediated YAP/TAZ knockdown or treatment of cells with verteporfin, an inhibitor of YAP
that disrupts the YAP/TEAD complex, blocked induction of cell spreading, actin
polymerization and fibrogenic gene expression (e.g., Acta2 and Col1a1) in response to acti-
vating culture conditions [104, 105]. Further, treatment of mice with verteporfin is able to
ameliorate fibrosis in mice injected with CCl4 [105]. In lung fibrosis, plasminogen activator
inhibitor-1 (encoded by SERPINE1) was identified as a YAP/TAZ target gene that promotes
cell-matrix adhesion and continual YAP/TAZ activation [104]. Thus YAP and TAZ operate
in a fibrotic positive-feedback loop, resulting in persistent cellular activation and patho-
logical fibrosis.
Activation of YAP and TAZ has long been associated with tumorigenesis due to up-
regulation of oncogenic gene targets promoting proliferation and resistance to apop-
tosis. Recent evidence suggests that cancer progression mediated by YAP/TAZ is due
to its role in promoting matrix stiffness, cancer cell invasion and angiogenesis. Cancer
associated fibroblasts are found in many solid tumours and promote the growth and in-
vasion of cancer cells by various mechanisms (see review by [106]). Notably, activation
of YAP (and most likely TAZ) is required for cancer associated fibroblast function
[107]. YAP induces the expression of several cytoskeletal regulators such as ANLN and
DIAPH3 to promote ECM remodeling and invasion. Consistent with this, nuclear accu-
mulation of YAP positively correlates with more advanced and aggressive human breast
tumours with increased ECM rigidity indicated by linearization (cross-linking) of colla-
gen bundles [108].
Resistance to chemotherapeutic agents is another trait of cancer cells exhibiting in-
creased YAP/TAZ activation. Studies of breast cancer cells found that increased TAZ
expression correlates with resistance to traditional chemotherapeutics paclitaxel and
doxorubicin [109, 110]. Moreover, silencing of TAZ in xeno-transplanted human breast
cancer stem cells significantly increased the efficiency of chemotherapy in vivo [111].
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cetuximab resistance in colorectal cancer patients [112]. Recently, using BRAF mutant
melanoma cell lines, Kim et al. [113] showed an increase in nuclear accumulation of
YAP/TAZ, accompanied by a concomitant increase in stress fiber formation, during the
development of vemurafenib resistance. This result is important since it is the first to
link actin dynamics and subsequent YAP/TAZ regulation to the acquisition of drug re-
sistance. These findings indicate that down-regulation of TAZ/YAP expression or in-
hibition of actin remodeling in tumours, coupled with- or prior to- administration of
chemotherapy, may have significant therapeutic value.
Additional mediators of actin-regulated gene transcription
Whilst MRTFs and YAP/TAZ are the most well characterised actin regulated transcrip-
tion factors, several additional mechanically regulated factors have been identified in-
cluding β-catenin, the NF-κB, Nrf2 and Foxj1a transcription factors, and epigenetic
regulator HDAC3. Cadherin-catenin complexes are responsible for mediating cell-cell
adhesion (e.g., adherens junctions) and typically comprise classical cadherins such as E-
cadherin, β-catenin, and α-catenin, which facilitates binding to vinculin, α-actinin and
actin. Cadherin-catenin complexes participate in mechanosignaling by transmission of
actomyosin-generated forces throughout a tissue (reviewed in [114]). β-catenin is a
transcriptional co-activator whose activity is hypothesised to be regulated by recruit-
ment and release from cadherin complexes. This is supported by the finding that over-
expression of activated ROCK2 in mouse skin results in stiffness-mediated activation of
β-catenin characterised by translocation from cell surface E-cadherin to the nucleus,
and up-regulation of β-catenin target genes, in particular Cyclin D1, to drive epidermal
hyperproliferation and consequent skin thickening [115]. Importantly, inhibition of
actomyosin contractility or deletion of β-catenin could abolish the effects of ROCK-
overexpression.
Mechanical stretching of lung parenchyma increases activation of NF-κB and AP-1
transcription factors via stretch-activated channels [116]. Activation of MAP kinase
signaling, a known regulator of NF-κB and AP-1, were responsible for their increased
activity. Moreover, NF-κB mediates up-regulation of cyclooxygenase-2 [116], a pro-
inflammatory gene associated with asthma that is also increased by mechanical stretch of
uterine myocytes in vitro [117] and during pregnancy and labour. Fluid shear stress stimu-
lates increased protein expression and nuclear localisation of the Nrf2 transcription factor
in endothelial cells in a phosphatidylinositol 3-kinase-dependent manner [118]. Shear
stress induces expression of Nrf2 target gene heme-oxygenase 1, which is an antioxidant
known to offer protection from development of atherosclerotic lesions in regions of high
fluid shear stress (reviewed by [119]). Moreover, in response to epithelial distension and
stretch caused by increased fluid pressure, the Foxj1a transcription factor is activated, me-
diating cilia motility in zebrafish [120].
In addition to gene specific activation in response to altered cellular tension, increased
actomyosin contractility correlates with increased levels of global histone H3 lysine 9
acetylation, a marker of transcriptional activation [121]. Interestingly, perturbation of
actomyosin contractility by treatment with blebbistatin, latrunculin A or cytochalasin D
results in cytoplasmic-to-nuclear redistribution of HDAC3 and subsequent reduction in
global histone acetylation levels [121]. This phenomenon is hypothesised to involve the
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cytoplasm. Thus actin dynamics play a crucial role in the regulation of global gene expres-
sion via maintenance of an acetylated “active” chromatin structure.Crosstalk and cooperation of mechanotransduction pathways
Several publications have identified crosstalk and cooperation between the mechanosensing
pathways covered by this review (Fig. 3c). YAP negatively regulates myocardin expression as
well as its association with SRF to control the phenotypic switch of vascular smooth muscle
cells in response to stimulation with platelet-derived growth factor. Overexpression of YAP
inhibited contractile gene expression including α-SMA, SM22α, SMMHC and MYOCD it-
self, whilst promoting transcription of pro-proliferative genes [122]. YAP was found to spe-
cifically interact with myocardin, which reduced its co-immunoprecipitation with SRF,
hence reducing SRF-directed transcription of smooth muscle genes (Fig. 3c). YAP therefore
plays a functional role in controlling the vascular smooth muscle cell phenotype in a
myocardin-dependent manner. This is functionally relevant in response to vascular injury
(e.g., balloon injury-induced vessel lesion formation) in which YAP expression is induced
[122]. Under these conditions YAP acts as a negative regulator of SRF-mediated gene tran-
scription. However in another study YAP and MRTF-A were found to cooperate to pro-
mote GPCR/RhoA stimulated gene transcription and cellular proliferation [123] (Fig. 3c).
Knockdown of YAP or MRTF-A blocked induction of CCN1 (Cyr61) expression stimulated
by S1P-mediated activation of GPCRs in glioblastoma cells. Like myocardin, MRTF-A was
found to associate with YAP in co-immunoprecipitation experiments following GPCR
stimulation. Functionally, both YAP and MRTF-A bind to the CCN1 promoter to drive
S1P-stimulated glioblastoma cell proliferation [123]. Consistent with this, a recent paper by
Cui et al. [93] reported that knockdown of either MRTF-A or YAP blocked cyclic stretch-
stimulated spreading and proliferation of primary mouse embryonic fibroblasts on soft sur-
faces. Interestingly, knockdown of either YAP or MRTF-A impeded nuclear localisation of
the other protein in response to cyclic stretching, though the mechanism of this regulation
is yet to be elucidated.
More recently, two reports identified a link between MRTF and TAZ [124, 125]. MRTF/
SRF signaling promotes TAZ gene expression and protein abundance downstream of activa-
tion by heregulin β1 in breast cancer cells [124]. Comparably, MRTF knockdown in a por-
cine kidney cell line resulted in significant down-regulation of TAZ mRNA and protein
[125]. Similar to previous reports that found MRTFs could interact directly with YAP,
Speight et al. [125] demonstrated that TAZ and MRTF associate, at least in part, by WW
domain/PPxY-mediated interaction [126, 127]. Importantly however, the authors elegantly
showed that despite their interaction, MRTF and TAZ translocate independently to the nu-
cleus upon actin polymerization [125]. In fact, in an interestingly complex scheme of pro-
tein crosstalk, TAZ and MRTF reciprocally mitigate each other’s nuclear localisation and
accumulation induced by low calcium (Fig. 3c). This observation is hypothesised to be me-
diated by TAZ-MRTF interaction, which may sequester both proteins in the cytoplasm. Fur-
thermore, MRTF was found to up-regulate 14-3-3 expression, which is expected to increase
cytoplasmic sequestration of both TAZ and YAP [125]. The crosstalk between these tran-
scriptional co-factors is significant in light of the knowledge that interaction of TAZ and
MRTF can have different transcriptional outcomes. Specifically, TAZ and MRTF antagonize
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cated neat to a SRE/CArG sequence [125].
Heregulin β1 (a splicing isoform of neuregulin 1) is a soluble protein that binds to and ac-
tivates the receptor protein tyrosine kinase ERBB4. Upon activation, the intracellular cyto-
plasmic domain (ICD) of ERBB4 translocates to the nucleus where it can activate
transcription. Via a WW domain/PPxY-mediated interaction, YAP interacts with ERBB4
ICD to stimulate transcription [128]. This interaction, producing a YAP-TEAD-ERBB4 tri-
partite complex, was later shown to induce YAP target genes such as CTGF, and promoted
YAP-dependent cell migration in response to neuregulin treatment in mammary carcinoma
cells [129]. Interestingly, protein tyrosine kinases (including ERBB4) are principally involved
in the formation of focal adhesions and rigidity sensing (reviewed in [130]). Knockdown of
ERBB4 in cultured human fibroblasts significantly reduced rigidity-dependent cell
polarization, characterised by reduced cell elongation and focal adhesion alignment, but
with increased focal adhesion number, on both soft and rigid substrates [131]. These find-
ings reveal that activation of ERBB4 via chemical (heregulin β1/neuregulin signaling) or
mechanical (rigidity) cues can alter YAP/TAZ signaling via two different mechanisms.
Hence ERBB4 should be considered to be a key regulator of YAP/TAZ activity.
As discussed above, MRTF associates with Smad3 to drive slug expression [27]. Intri-
guingly, Smad3 inhibits MRTF-dependent activation of the α-SMA promoter by reducing
MRTF association with SRF [132] (Fig. 3c). TAZ has also been reported to cooperate with
Smad3 to drive expression of α-SMA, and in an additional layer of complexity, treatment
with TGFβ altered the relative interaction between MRTF, Smad3 and TAZ [125]. This is
meaningful since TGFβ is a potent biochemical inducer of fibrogenesis, mediated by down-
stream MRTF signaling, thus the relative abundance of these multiple signaling mediators,
in addition to the mechano- and chemical- stimuli detected by cells will precisely dictate
the response at the level of gene transcription.
As another example of crosstalk between mechanosensing pathways, β-catenin was
identified to be a positive regulator of MRTF signaling by alleviation of Smad3 inhibition
via two mechanisms [133] (Fig. 3c). First, β-catenin competes with Smad3 for MRTF
binding, freeing MRTF to associate with SRF. Second, β-catenin supresses Smad3-
mediated recruitment of glycogen synthase kinase-3β to MRTF that leads to its ubiquiti-
nation and degradation, thus increasing MRTF protein stability [133]. Interestingly, YAP
and β-catenin cooperate to regulate mechanical strain induced cell proliferation [134].
Cell cycle re-entry and subsequent progression from G1 to S phase are mediated by YAP-
and β-catenin- signaling respectively, however inhibition of either is sufficient to block
cellular proliferation as determined by Edu incorporation. Notably, treatment with inhibi-
tors to block YAP activity (e.g., YAP1-TEAD inhibitory peptide or verteporfin) also
blocked cell cycle entry evidenced by a marked reduction in Ki67 positive staining [134].
Thus, through different but complementary roles, YAP and β-catenin coordinate to regu-
late biological function (Fig. 3c).
Other points of interest
In this review we have touched on some of the reports of crosstalk and cooperation of
various mechanosensitive transcriptional activators either via physical association or regu-
lation of gene expression. Important to note however is that DNA transcription is not an
absolute requirement for a cell’s response to mechanical stimuli. Indeed experiments have
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and through basement membrane and endothelium towards a chemoattractant source
[135, 136]. Furthermore, there is evidence to suggest that shedding of anucleate cytoplas-
mic fragments (microplasts) correlates with tumour cell invasiveness [137], suggesting
that cell fragments may play a significant biological role, and could potentially be har-
nessed as vectors to deliver therapeutic agents. Localised force sensing and feedback
mechanisms exist that enable cells, and even tiny cell fragments, to sense and respond to
mechanical cues. Whilst the longer-term downstream effects of these events may still
reach the cell nucleus to regulate gene expression, there are several examples of molecules
and molecular complexes that can respond directly to mechanical stimuli, including adhe-
sion complexes, the actomyosin network, and mechanosesitive ion channels (reviewed in
[138]), which we will discuss briefly here.
Cells interact with each other and their environment via the formation of various adhe-
sion complexes. Focal adhesions in particular have been shown to behave as individual
mechanosensors. In response to applied force, focal adhesions exhibit directional assembly
resulting in elongation [139], and this was found to be the result of stretching of several
focal adhesion proteins exposing hidden binding sites for partner proteins. Similarly,
strengthening of intercellular adherens junctions, mediated by protein clustering, is ob-
served upon direct application of mechanical force [140]. Mechanical forces can also regu-
late the dynamics of the actomyosin network comprised of F-actin filaments cross-linked by
the myosin II molecular motor. Load stabilises myosin in a state that sustains tension [141].
Furthermore, the elongation rate of formin mDia1 is increased up to two-fold by mechan-
ical pulling, hypothesised to be due to the fact that pulling force favours the ‘open’ conform-
ation, allowing an additional actin subunit to be added at the filament end [142]. Finally,
mechanosensitive ion channels, also known as stretch-gated ion channels, respond directly
to changes in cellular membrane tension by undergoing a conformational change to trans-
late external physical stimuli into electrical signals. Other mechanosensitive channels are
coupled to the cell cytoskeleton, thus movement of the cell relative to the ECM can also ac-
tivate these channels. Flux of particular ions, such as Ca2+, induces a variety of cell re-
sponses including regulation of actin dynamics affecting cell contractility, mobility and
adhesion formation (reviewed in [143]).
Crosstalk between the various mechanosensitive transcriptional activators discussed in this
review can be seemingly straightforward: as in the direct binding of YAP/TAZ with myocar-
din/MRTF, or involve multiple competing and complimentary interactions between several
factors: such as all combinations of SMAD or β-catenin with YAP, TAZ and MRTF. Whilst
these are important and interesting examples of signaling crosstalk, they are not necessarily
limited to direct protein-protein interactions. In the elegant study by Zanconato et al. [144]
for example, the authors show that the YAP/TAZ/TEAD complex synergizes with the “classic
proto-oncogene” AP-1 factors that are bound to composite cis-regulatory elements. Though
AP-1 factors do not mediate YAP/TAZ DNA binding, nor was there evidence to suggest the
main AP-1 proteins interact directly with YAP/TAZ, AP-1 factors jointly regulate a slew of
YAP/TAZ/TEAD target genes that enhance YAP-dependent oncogenic activity [144]. Care
should therefore be taken when examining mechanosensitive signaling pathways, remember-
ing that they do not operate in isolation. Altering the expression or activity of even a single
mediator will have far-reaching implications, and we predict the complexity will only in-
crease, as these important new layers of signaling pathway integration are uncovered.
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man cancer types myocardin was identified as a new oncogene that is mutated in cancer
[145]. Interestingly, a cluster of nine mutations was identified within the region of myocar-
din that encodes the conserved PPxY motif that is responsible for YAP/TAZ/MYOCD
interaction. It would be of interest to explore this finding to determine whether YAP/TAZ
interaction with myocardin is compromised in these tumours, and whether this plays a role
in their oncogenic phenotype, since if YAP and myocardin can no longer interact, their
interaction with other mediators would be favoured to mediate different signaling out-
comes. This study highlights the potential for studies of large sample size to detect previ-
ously undetected, yet highly relevant, cancer causing mutations that will help to guide our
understanding of the complex interactions between known signal transduction pathways.
A feature of YAP signaling that is relatively unexplored, yet may yield significant insight
into mechanotransduction mechanisms, is the potential differences between YAP splicing
isoforms. There are at least eight reported isoforms of human YAP that are detectable as
RNA in a range of human tissues [146]. Studies comparing various YAP isoforms have
identified differences with regards to protein-protein interactions, e.g., with ERBB4 [128],
AMOT [147], and p73 [59], as well as their relative transcriptional coactivator activities
[128, 148]. Thus whether differential expression of YAP isoforms can influence mechano-
transduction induced by mechanical cues, and whether this is linked to YAP-isoform spe-
cific interactions with other mechanosensitive mediators, remains to be determined.Conclusions
Cells within a tissue exist in a complex environment that is constantly changing. Cells need
to be able to sense and respond accordingly to the multitude of signals they encounter,
which includes mechanical cues such as pushing, pulling and shear stress. Regulation of gene
transcription by actin dynamics is absolutely crucial to coordinate complex processes such
as migration, mitosis, and intracellular trafficking. Transcription factors that form complexes
with actin binding proteins, or bind directly to actin itself are going to be particularly respon-
sive to actin dynamics. The MRTFs and Hippo pathway effectors YAP and TAZ are well-
characterised examples of mechano-responsive transcription factors. As we learn more
about the players and processes of actin dynamics we anticipate that new mechanotransdu-
cers will be identified. These discoveries will have important implications for understanding
development and disease, and how these factors might be targeted therapeutically.
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